Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Circulation. Cardiovascular Quality and Outcomes|April 9, 2018
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) RegistryYevgeniy Khariton, Adrian F Hernandez, Gregg C Fonarow, et al.
JACC. Heart Failure|June 2, 2018
Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart FailureYevgeniy Khariton, Michael E Nassif, Laine Thomas, et al.
Circulation. Heart Failure|October 18, 2017
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical TrialsMichael E Nassif, Yuanyuan Tang, John G Cleland, et al.
Journal of Cardiac Failure|December 28, 2020
Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound AnalysisBrett W Sperry, Raed Qarajeh, Mohamed A Omer, et al.
ESC Heart Failure|May 1, 2021
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fractionMerrill Thomas, Yevgeniy Khariton, Gregg C Fonarow, et al.
Circulation. Heart Failure|October 23, 2023
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HFGregory D Lewis, Kensey Gosch, Laura P Cohen, et al.
JACC. Heart Failure|September 16, 2019
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection FractionYevgeniy Khariton, Gregg C Fonarow, Suzanne V Arnold, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Pageof 9